Active	Status	Sponsor type	Region	Phase	Filter
4 Active 6 Inactive 10 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

4 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Siragusa, Sergio
Phoenix, NCT05924100 / 2021-001538-20: Efficacy and Safety of Luspatercept for the Treatment of Anemia Due to MDS With del5q, Refractory/Resistant/Intolerant to Prior Treatments, RBC-TD	Recruiting	2	22	Europe	Luspatercept Injection [Reblozyl]	Associazione Qol-one, Celgene BMS	Myelodysplastic Syndromes, Del(5Q), Anemia, Transfusion-dependent Anemia	12/24	12/29
NCT04352556: COVID19-hematological Malignancies: the Italian Hematology Alliance	Recruiting	N/A	250	Europe		Ospedale di Circolo - Fondazione Macchi	SARS-CoV-2 Infection, Hematological Malignancies	10/22	10/22
ITP0918, NCT03465020: Investigation on a Dynamic Cohort of Italian Patients With Active ITP	Recruiting	N/A	861	Europe	Observation	Gruppo Italiano Malattie EMatologiche dell'Adulto, Hematology Project Foundation	Idiopathic Thrombocytopenic Purpura	07/23	07/23
CLARITY, NCT03190525: Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma	Recruiting	N/A	520	Europe	Quality of life questionnaires	Gruppo Italiano Malattie EMatologiche dell'Adulto	Multiple Myeloma	12/24	12/24